Cargando…
Selective amyloid-β lowering agents
The amyloid-β peptide (Aβ), implicated in the pathogenesis of Alzheimer's disease (AD), is produced through sequential proteolysis of the Aβ precursor protein (APP) by β- and γ-secretases. Thus, blocking either of these two proteases, directly or indirectly, is potentially worthwhile toward dev...
Autor principal: | Wolfe, Michael S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604888/ https://www.ncbi.nlm.nih.gov/pubmed/19090992 http://dx.doi.org/10.1186/1471-2202-9-S2-S4 |
Ejemplares similares
-
Critical Appraisal of Amyloid Lowering Agents in AD
por: Decourt, Boris, et al.
Publicado: (2021) -
SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques
por: Ono, Masahiro, et al.
Publicado: (2011) -
Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
por: Batarseh, Yazan S., et al.
Publicado: (2016) -
Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production
por: Khan, Ayesha, et al.
Publicado: (2023) -
Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
por: Wilczyńska, Karolina, et al.
Publicado: (2020)